CRITICAL THERAPEUTICS INC (CRTX) has 57 open-market insider trades by 28 insiders since 2006. The most active filer is David Lamond, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Farmaceutici SpA Chiesi | 10% | — | 3 | $118.7M | 2014-02-03 |
| Craig A. Collard | CEO | — | 3 | $18.2M | 2014-02-03 |
| David Lamond | Dir | — | 4 | $15.3M | 2022-05-19 |
| Pfizer Strategic Investment Holdings LLC | 10% Owner | — | 1 | $14.9M | 2020-06-03 |
| BioPharma Holdings Ltd. Cornerstone | 10% | — | 1 | $6.9M | 2009-07-28 |
| James B. Tananbaum | Dir | — | 4 | $5.9M | 2007-06-14 |
| Casey Lynch | CEO | — | 3 | $4.3M | 2021-11-18 |
| Michael J. Detke | — | — | 2 | $4.1M | 2022-03-03 |
| Christopher P. Lowe | COOCFO | — | 3 | $3.7M | 2022-03-03 |
| Steven Michael Lutz | PresVP | — | 2 | $2.3M | 2010-12-16 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Caryn Gordon McDowell | Chief Legal & Adm. Officer | Sell | $31K | 2022-06-06 |
| Stephen S. Dominy | Chief Scientific Officer | Buy | $11K | 2021-11-12 |
| Margaret McLoughlin | Director | Sell | $89K | 2021-10-08 |
| Christopher P. Lowe | COO & CFO | Sell | $978K | 2021-10-05 |
| Margaret McLoughlin | Director | Sell | $1.1M | 2021-08-16 |
| Christopher P. Lowe | COO & CFO | Sell | $4.1M |
Companies that share insiders with CRTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-08-16 |
| Michael J. Detke | — | Sell | $1.0M | 2021-08-10 |
| Michael J. Detke | — | Sell | $6.3M | 2021-07-06 |
| Christopher P. Lowe | COO & CFO | Sell | $2.2M | 2021-06-28 |
| Margaret McLoughlin | Director | Sell | $30K | 2021-06-28 |
| Casey Lynch | CEO | Sell | $1.6M | 2021-05-10 |
| David Lamond | Director | Buy | $3.4M | 2021-03-24 |
| Casey Lynch | CEO | Sell | $2.1M | 2021-03-22 |
| David Lamond | Director | Buy | $2.9M | 2021-03-04 |
| Casey Lynch | CEO | Sell | $3.9M | 2021-02-01 |